Western blots assaying xenografted tumor lysates showed that AKT-S6 activations as well as cyclin D1 expression were significantly inhibited by VS-5584 or plus ABT-737 treatment in vivo (Fig 5D), which are consistent with the in vitro findings. Here, RPS6 is linked to neoplasm.